• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2009 Medical Advisory Secretariat (MAS) Magnetic resonance (MR) colonography for colorectal cancer screening: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Community-based care for the specialized management of heart failure: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Airway clearance devices for cystic fibrosis
2009 Medical Advisory Secretariat (MAS) Ultraviolet phototherapy management of moderate-to-severe plaque psoriasis: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Capsule endoscopy for colorectal cancer screening: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Flexible sigmoidoscopy for colorectal cancer screening: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Fecal occult blood test for colorectal cancer screening: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Computed tomographic (CT) colonography for colorectal cancer screening: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Multidisciplinary community-based care for chronic wound management: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Continuous subcutaneous insulin infusion (CSII) pumps for type 1 and type 2 adult diabetic populations: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Behavioural interventions for type 2 diabetes: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Community-based care for the management of type 2 diabetes: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Home telemonitoring for type 2 diabetes: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Application of the Ontario diabetes economic model (ODEM) to determine the cost-effectiveness and budget impact of selected type 2 diabetes interventions in Ontario
2009 Norwegian Knowledge Centre for the Health Services (NOKC) Do staff educational programmes affect end-of-life care in nursing homes?
2009 Norwegian Knowledge Centre for the Health Services (NOKC) Rehabilitation of breast cancer patients
2009 Norwegian Knowledge Centre for the Health Services (NOKC) Skills laboratories: virtual training of manual and practical skills
2009 Norwegian Knowledge Centre for the Health Services (NOKC) Misoprostol for induction of labour
2009 Norwegian Knowledge Centre for the Health Services (NOKC) Effects of psychotherapy for adults with depression
2009 Norwegian Knowledge Centre for the Health Services (NOKC) Efficacy and safety of first-generation and and second- generations antipsychotic drugs for schizophrenia in adults. An overview of systematic reviews.
2009 Norwegian Knowledge Centre for the Health Services (NOKC) Influenza vaccination of elderly and people with chronic illness
2009 Norwegian Knowledge Centre for the Health Services (NOKC) Effects of the built environment and elements therein on people with dementia
2009 Norwegian Knowledge Centre for the Health Services (NOKC) The importance of personnel competence to achieve social participation and activity amongst users of municipal home care
2009 Norwegian Knowledge Centre for the Health Services (NOKC) Treatment of infantile colic
2009 Norwegian Knowledge Centre for the Health Services (NOKC) Coercive treatment of persons dependent on opioids
2009 Norwegian Knowledge Centre for the Health Services (NOKC) Diagnostics and treatment of infant suspected with kinematic imbalance due to suboccipital strain (KISS)
2009 Technology Assessment Unit of the McGill University Health Centre (MUHC) Opportunity costs associated with technology expansion in the MUHC
2009 Technology Assessment Unit of the McGill University Health Centre (MUHC) The Impella percutaneous ventricular assist device
2009 Technology Assessment Unit of the McGill University Health Centre (MUHC) Subthalamic deep brain stimulation (DBS): clinical efficacy, safety and cost compared to medical therapy for the treatment of Parkinson's Disease
2009 Technology Assessment Unit of the McGill University Health Centre (MUHC) Percutaneous radiofrequency ablation for treatment of hepatocellular carcinoma
2009 Technology Assessment Unit of the McGill University Health Centre (MUHC) Clinical efficacy and cost of Allogenic Acellular Dermal Matrix (AADM) in implant-based breast reconstruction of post mastectomy cancer patients
2009 Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of matrix coils in the treatment of cerebro-vascular aneurysms: an update
2009 Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy and cost-effectiveness of Collatamp-G for infection prophylaxis in cardiac surgery
2009 Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of probiotics in the prevention and treatment of clostridium difficile diarrhea: an update
2009 Technology Assessment Unit of the McGill University Health Centre (MUHC) Transcatheter Aortic Valve Implantation (TAVI) at the MUHC: a Health Technology Assessment
2009 Technology Assessment Unit of the McGill University Health Centre (MUHC) Radiofrequency ablation for treatment of Barrett's esophagus: A systematic review and cost analysis
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting Beta2-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: systematic review of clinical outcomes and economic evaluation
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Child and adolescent psychiatry. (Part 2) - A systematic review of health economic evaluations
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) New influenza (swine flu) - data & facts for decision support
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cetuximab (Erbitux) in EGFR-expressing Non-Small Cell Lung Cancer
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Everolimus (Afinitor) for advanced/metastatic kidney cancer
2009 Blue Cross Blue Shield Association (BCBS) CT colonography (virtual colonoscopy) for colon cancer screening
2009 Blue Cross Blue Shield Association (BCBS) Special report: critical appraisal of CT colonography cost-effectiveness analyses
2009 Blue Cross Blue Shield Association (BCBS) Artificial intervertebral disc arthroplasty for treatment of degenerative disc disease of the cervical spine
2009 Blue Cross Blue Shield Association (BCBS) Off-label use of bevacizumab: advanced adenocarcinoma of the pancreas
2009 Blue Cross Blue Shield Association (BCBS) Transcranial magnetic stimulation for depression
2009 Technology Assessment Unit of the McGill University Health Centre (MUHC) [The use of carmustine implants (Gliadel wafers) in patients with malignant glioma]
2009 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Curative treatment for esophageal cancer: systematic review of neoadjuvant therapy and chemoradiotherapy alone: summary]
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Classification of disease severity for neuro- and trauma rehabilitation. Part 2: international experiences with quality / performance assessments and reimbursement
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Acquisition processes of certain product groups in hospitals - orthopaedic and cardiac implants.
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Haemocomplettan P alone or in combination with Fibrogammin P in acquired hypofibrinogenemia.
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Stent-grafting of the ascending aorta. Systematic review - 1st update 2009
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cardiac contractility modulation for heart failure. Systematic review - 1st update 2009
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Percutaneous aortic valve replacement. Systematic review - 1st update 2009
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rituximab (Rituxan/MabThera) for the first- and second-line treatment of chronic lymphocytic leukaemia
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ibritumomab tiuxetan (Zevalin) as consolidation therapy after first remission in patients with follicular lymphoma
2009 Institute for Clinical Effectiveness and Health Policy (IECS) [Inhaled tobramycin for cystic fibrosis]
2009 NIHR Health Technology Assessment programme Funding to cover the costs incurred to hold the 4th International Balliol Surgical Trials Colloquia
2009 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Observation of technologies after their introduction into clinical practice. Prioritisation and assessment protocol proposal]
2009 The Swedish Council on Health Technology Assessment (SBU) [How can drug consumption among the elderly be improved?]
2009 Health Information and Quality Authority (HIQA) Health technology assessment (HTA) of a population-based colorectal cancer screening programme in Ireland
2009 NIHR Horizon Scanning Centre (NIHR HSC) Spiral Laminar Flow bypass graft for peripheral arterial disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) Pregabalin (Lyrica) for partial onset epilepsy - monotherapy
2009 NIHR Horizon Scanning Centre (NIHR HSC) Dasatinib (Sprycel) for chronic myeloid leukaemia - first line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Carisbamate for partial onset epilepsy
2009 NIHR Horizon Scanning Centre (NIHR HSC) Everolimus for autosomal dominant polycystic kidney disease with renal impairment
2009 NIHR Horizon Scanning Centre (NIHR HSC) HandTutor for hand rehabilitation
2009 NIHR Horizon Scanning Centre (NIHR HSC) Teduglutide for short bowel syndrome
2009 NIHR Horizon Scanning Centre (NIHR HSC) Tapentadol (Palexia) prolonged-release for severe chronic pain
2009 NIHR Horizon Scanning Centre (NIHR HSC) Tapentadol (Palexia) for severe acute pain
2009 NIHR Horizon Scanning Centre (NIHR HSC) Ridaforolimus for unresectable locally advanced and metastatic soft tissue and bone sarcoma - maintenance therapy
2009 NIHR Horizon Scanning Centre (NIHR HSC) Pixantrone dimaleate for relapsed or refractory aggressive non-Hodgkin's lymphoma
2009 NIHR Horizon Scanning Centre (NIHR HSC) Fluocinolone acetonide intravitreal insert (Iluvien) for diabetic macular oedema
2009 NIHR Horizon Scanning Centre (NIHR HSC) Denufosol for cystic fibrosis with mild lung disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) BIBF 1120 for advanced and/or metastatic non-small cell lung cancer - second line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for advanced metastatic ovarian cancer
2009 NIHR Horizon Scanning Centre (NIHR HSC) Belimumab (Benlysta) for active systemic lupus erythematosus
2009 NIHR Horizon Scanning Centre (NIHR HSC) Alvocidib (Flavopiridol) for refractory/relapsed chronic lymphocytic leukaemia
2009 NIHR Horizon Scanning Centre (NIHR HSC) Adalimumab (Humira) for children with Crohn's disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) Transcranial direct current stimulation (tDCS) for major depressive disorder
2009 NIHR Horizon Scanning Centre (NIHR HSC) Transcranial direct current stimulation (tDCS) for Alzheimer's disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) Sativex for spasticity in multiple sclerosis
2009 NIHR Horizon Scanning Centre (NIHR HSC) Eslicarbazepine acetate for partial onset epilepsy - refractory
2009 NIHR Horizon Scanning Centre (NIHR HSC) Aripiprazole (Abilify) for major depressive disorder
2009 NIHR Horizon Scanning Centre (NIHR HSC) High dose fulvestrant (Faslodex) for locally advanced or metastatic breast cancer
2009 NIHR Horizon Scanning Centre (NIHR HSC) Bivalirudin (Angiox) for acute myocardial infarction with persistent ST-segment elevation treated by primary percutaneous coronary intervention
2009 NIHR Horizon Scanning Centre (NIHR HSC) Velaglucerase alfa for type 1 Gaucher's disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) Sodium oxybate (Xyrem) for fibromyalgia - first line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Roflumilast (Daxas) for chronic obstructive pulmonary disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) Adalimumab (Humira) for ulcerative colitis
2009 NIHR Horizon Scanning Centre (NIHR HSC) Abatacept (Orencia) for active rheumatoid arthritis
2009 NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Xarelto) for stroke prevention in atrial fibrillation
2009 NIHR Horizon Scanning Centre (NIHR HSC) Risperidone long-acting injection (Risperdal Consta) for prevention of recurrent episodes in bipolar 1 disorder
2009 NIHR Horizon Scanning Centre (NIHR HSC) Rilonacept for cryopyrin associated periodic syndromes
2009 NIHR Horizon Scanning Centre (NIHR HSC) Pralatrexate for peripheral T-cell lymphoma - relapsed and/or refractory
2009 NIHR Horizon Scanning Centre (NIHR HSC) Laromustine (Onrigin) for acute myeloid leukaemia in newly diagnosed elderly patients - induction therapy
2009 NIHR Horizon Scanning Centre (NIHR HSC) Dexamethasone intravitreal implant (Posurdex) for macular oedema secondary to central or branch retinal vein occlusion
2009 NIHR Horizon Scanning Centre (NIHR HSC) Colistimethate sodium powder for inhalation (Colobreathe) for pseudomonas aeruginosa lung infection in cystic fibrosis
2009 NIHR Horizon Scanning Centre (NIHR HSC) Clevidipine (Cleviprex) for acute hypertension